Differences amid bone marrow and cord blood hematopoietic stem/progenitor cell division kinetics

Journal of Cellular Physiology

Volumn 220, Issue 1, 2009, Pages 102-111

  Da Silva, Cláudia Lobato ^a,b   Gonçalves, Raquel ^a,b   Porada, Christopher D ^a   Ascensão, João L ^c   Zanjani, Esmail D ^a   Cabral, Joaquim M S ^b   Almeida Porada, Graça ^a  

^a UNIVERSITY OF NEVADA   (United States)

^b INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; BIOLOGICAL MARKER; CD38 PROTEIN, HUMAN; FLUORESCENT DYE; MEMBRANE PROTEIN; ORGANIC COMPOUND; PKH67;

ANTIGEN EXPRESSION; ARTICLE; CELL DIVISION; CELL KINETICS; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; CORD BLOOD STEM CELL; DOWN REGULATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MITOSIS; NORMAL HUMAN; PRIORITY JOURNAL; STEM CELL; BONE MARROW CELL; CELL CULTURE; CELL SEPARATION; COMPARATIVE STUDY; CYTOLOGY; FETUS BLOOD; FLOW CYTOMETRY; IMMUNOLOGY; IMMUNOPHENOTYPING; KINETICS; MESENCHYMAL STEM CELL; METABOLISM; METHODOLOGY; PHENOTYPE; PHYSIOLOGY; TIME;

ANTIGENS, CD34; ANTIGENS, CD38; BIOLOGICAL MARKERS; BONE MARROW CELLS; CELL PROLIFERATION; CELL SEPARATION; CELLS, CULTURED; FETAL BLOOD; FLOW CYTOMETRY; FLUORESCENT DYES; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; KINETICS; MEMBRANE GLYCOPROTEINS; MESENCHYMAL STEM CELLS; MITOSIS; ORGANIC CHEMICALS; PHENOTYPE; TIME FACTORS;

EID: 65549085564     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21736     Document Type: Article

References (46)

1. Almeida-Porada G, Brown RL, MacKintosh FR, Zanjani ED. 2000. Evaluation of serum-free culture conditions able to support the ex vivo expansion and engraftment of human hematopoietic stem cells in the human-to-sheep xenograft model. J Hematother Stem Cell Res 9:683-693.
2. Baumhueter S, Dybdal N, Kyle C, Lasky LA. 1994. Global vascular expression of murine CD34, a sialomucin-like endothelial ligand for L-selectin. Blood 84:2554-2565.
3. Berenson RJ, Andrews RG, Bensinger WI, Kalamasz D, Knitter G, Buckner CD, Bernstein ID. 1988. Antigen CD34+ marrow cells engraft lethally irradiated baboons. J Clin Invest 81:951-955.
4. Berenson RJ, Bensinger WI, Hill RS, Andrews RG, Garcia-Lopez J, Kalamasz DF, Still BJ, Spitzer G, Buckner CD, Bernstein ID, Thomas ED. 1991. Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood 77:1717-1722.
5. Bhatia M, Bonnet D, Murdoch B, Gan OI, Dick JE. 1998. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med 4:1038-1045.
6. Brandt JE, Bartholomew AM, Fortman JD, Nelson MC, Bruno E, Chen LM, Turian JV, Davis TA, Chute JP, Hoffman R. 1999. Ex vivo expansion of autologous bone marrow CD34(+) cells with porcine microvascular endothelial cells results in a graft capable of rescuing lethally irradiated baboons. Blood 94:106-113.
7. Breard J, Reinherz EL, Kung PC, Goldstein G, Schlossman SF. 1980. A monoclonal antibody reactive with human peripheral blood monocytes. J Immunol 124:1943-1948.
8. Bullock TE, Wen B, Marley SB, Gordon MY. 2007. Potential of CD34 in the regulation of symmetrical and asymmetrical divisions by hematopoietic progenitor cells. Stem Cells (Dayton, OH) 25:844-851.
9. Chrysler GR, Mckenna MD, Shierman T, Kadidlo D, Askari S, Miller J, Clay M, McCullough J. 2004. Umbilical cord blood banking. In: Broxmeyer HE, editor. Cord Blood-Biology, Immunology, Banking and Clinical Transplantation. AABB Press.
10. Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH. 1984. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 133:157-165.
11. da Silva CL, Goncalves R, Crapnell KB, Cabral JM, Zanjani ED, Almeida-Porada G. 2005. A human stromal-based serum-free culture system supports the ex vivo expansion/ maintenance of bone marrow and cord blood hematopoietic stem/progenitor cells. Exp Hematol 33:828-835.
12. Dao MA, Arevalo J, Nolta JA. 2003. Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution. Blood 101:112-118.
13. Deaglio S, Zubiaur M, Gregorini A, Bottarel F, Ausiello CM, Dianzani U, Sancho J, Malavasi F. 2002. Human CD38 and CD16 are functionally dependent and physically associated in natural killer cells. Blood 99:2490-2498.
14. Dooley DC, Oppenlander BK, Xiao M. 2004. Analysis of primitive CD34- and CD34+ hematopoietic cells from adults: Gain and loss of CD34antigen by undifferentiated cells are closely linked to proliferative status in culture. Stem Cells (Dayton, OH) 22:556-569.
15. Drew E, Merzaban JS, Seo W, Ziltener HJ, McNagny KM. 2005. CD34 and CD43 inhibit mast cell adhesion and are required for optimal mast cell reconstitution. Immunity 22:43-57.
16. Givan AL, Fisher JL, Waugh M, Ernstoff MS, Wallace PK. 1999. A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J Immunol Methods 230:99-112.
17. Gonçalves R, da Silva CL, Cabral JM, Zanjani ED, Almeida-Porada G. 2006. AStro 1+universal stromal feeder layer to expand/maintain human bone marrow hematopoietic stem/progenitor cells in a serum-free culture system. Exp Hematol 34:1353-1359.
18. Hao QL, Shah AJ, Thiemann FT, Smogorzewska EM, Crooks GM. 1995. A functional comparison of CD34+ CD38- cells in cord blood and bone marrow. Blood 86:3745-3753.
19. Healy L, May G, Gale K, Grosveld F, Greaves M, Enver T. 1995. The stem cell antigen CD34 functions as a regulator of hemopoietic cell adhesion. Proc Natl Acad Sci USA 92:12240-12244.
20. Holyoake TL, Nicolini FE, Eaves CJ. 1999. Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. Exp Hematol 27:1418-1427.
21. Huang S, Law P, Francis K, Palsson BO, Ho AD. 1999. Symmetry of initial cell divisions among primitive hematopoietic progenitors is independent of ontogenic age and regulatory molecules. Blood 94:2595-2604.
22. Lansdorp PM. 1995a. Developmental changes in the function of hematopoietic stem cells. Exp Hematol 23:187-191.
23. Lansdorp PM. 1995b. Telomere length and proliferation potential of hematopoietic stem cells. J Cell Sci 108:1-6.
24. Lanza F, Healy L, Sutherland DR. 2001. Structural and functional features of the CD34 antigen: An update. J Biol Regul Homeost Agents 15:1-13.
25. Liu D, Yu J, Chen H, Reichman R, Wu H, Jin X. 2006. Statistical determination of threshold for cellular division in the CFSE-labeling assay. J Immunol Methods 312:126-136.
26. Luens KM, Travis MA, Chen BP, Hill BL, Scollay R, Murray LJ. 1998. Thrombopoietin, kit ligand, and flk2/flt3 ligand together induce increased numbers of primitive hematopoietic progenitors from human CD34+Thy-1+Lin- cells with preserved ability to engraft SCID-hu bone. Blood 91:1206-1215.
27. Mayani H, Lansdorp PM. 1998. Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells. Stem Cells (Dayton, OH) 16:153-165.
28. McKenzie JL, Gan OI, Doedens M, Dick JE. 2007. Reversible cell surface expression of CD38 on CD34-positive human hematopoietic repopulating cells. Exp Hematol 35:1429-1436.
29. Moritz T, Keller DC, Williams DA. 1993. Human cord blood cells as targets for gene transfer: Potential use in genetic therapies of severe combined immunodeficiency disease. J Exp Med 178:529-536.
30. Nakamura Y, Yahata T, Muguruma Y, Uno T, Sato T, Matsuzawa H, Kato S, Shirasugi Y, Hotta T, Ando K. 2007. Angiopoietin-1 supports induction of hematopoietic activity in human CD34- bone marrow cells. Exp Hematol 35:1872-1883.
31. Osawa M, Hanada K, Hamada H, Nakauchi H. 1996. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science (New York, NY) 273:242-245.
32. Salati S, Zini R, Bianchi E, Testa A, Mavilio F, Manfredini R, Ferrari S. 2008. Role of CD34 antigen in myeloid differentiation of human hematopoietic progenitor cells. Stem Cells (Dayton, OH) 26:950-959.
33. Sato T, Laver JH, Ogawa M. 1999. Reversible expression of CD34 by murine hematopoietic stem cells. Blood 94:2548-2554.
34. Schibler KR, Li Y, Ohls RK, Nye NC, Durham MC, White W, Liechty KW, Le T, Christensen RD. 1994. Possible mechanisms accounting for the growth factor independence of hematopoietic progenitors from umbilical cord blood. Blood 84:3679-3684.
35. Shpall EJ, Jones RB, Bearman SI, Franklin WA, Archer PG, Curiel T, Bitter M, Claman HN, Stemmer SM, Purdy M, Myers SE, Hami L, Taffs S, Heimfeld S, Hallagan J, Berenson RJ. 1994. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 12:28-36.
36. Stewart AK, Vescio R, Schiller G, Ballester O, Noga S, Rugo H, Freytes C, Stadtmauer E, Tarantolo S, Sahebi F, Stiff P, Meharchard J, Schlossman R, Brown R, Tully H, Benyunes M, Jacobs C, Berenson R, White M, DiPersio J, Anderson KC, Berenson J. 2001. Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: Results of a multicenter randomized controlled trial. J Clin Oncol 19:3771-3779.
37. Tajima F, Deguchi T, Laver JH, Zeng H, Ogawa M. 2001. Reciprocal expression of CD38 and CD34 by adult murine hematopoietic stem cells. Blood 97:2618-2624.
38. Theunissen K, Verfaillie CM. 2005. A multifactorial analysis of umbilical cord blood, adult bone marrow and mobilized peripheral blood progenitors using the improved ML-IC assay. Exp Hematol 33:165-172.
39. Traycoff CM, Abboud MR, Laver J, Clapp DW, Srour EF. 1994. Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential. Exp Hematol 22:1264-1272.
40. Traycoff CM, Kosak ST, Grigsby S, Srour EF. 1995. Evaluation of ex vivo expansion potential of cord blood and bone marrow hematopoietic progenitor cells using cell tracking and limiting dilution analysis. Blood 85:2059-2068.
41. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. 1994. Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age. Proc Natl Acad Sci USA 91:9857-9860.
42. Watari K, Lansdorp PM, Dragowska W, Mayani H, Schrader JW. 1994. Expression of interleukin-1 beta gene in candidate human hematopoietic stem cells. Blood 84:36-43.
43. Young JC, Varma A, DiGiusto D, Backer MP. 1996. Retention of quiescent hematopoietic cells with high proliferative potential during ex vivo stem cell culture. Blood 87:545-556.
44. Zanjani ED, Almeida-Porada G, Livingston AG, Flake AW, Ogawa M. 1998. Human bone marrow CD34- cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells. Exp Hematol 26:353-360.
45. Zanjani ED, Almeida-Porada G, Livingston AG, Zeng H, Ogawa M. 2003. Reversible expression of CD34 by adult human bone marrow long-term engrafting hematopoietic stem cells. Exp Hematol 31:406-412.
46. Zocchi E, Daga A, Usai C, Franco L, Guida L, Bruzzone S, Costa A, Marchetti C, De Flora A. 1998. Expression of CD38 increases intracellular calcium concentration and reduces doubling time in HeLa and 3T3 cells. J Biol Chem 273:8017-8024.